Day: December 30, 2019

SEATTLE, Dec. 30, 2019 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.Adaptive’s management is scheduled to present on Tuesday, January 14, 2020, at 1:30pm PT. Interested parties may access a webcast of the presentation on the “Investors” section of the company’s website at: http://investors.adaptivebiotech.com.About Adaptive BiotechnologiesAdaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system...

OAK BROOK, Ill., Dec. 30, 2019 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes”) (NASDAQ:GLDD), the largest provider of dredging services in the United States announced today the receipt of several major dredging awards totaling $83 million.The awarded work includes:Charlotte/Sarasota Regional Beach Project (Coastal Protection, Florida, $30.5 million)South Atlantic Region Harbor Dredging (Maintenance, Georgia and North Carolina, $13.9 million)Chester, Pennsylvania Modification Project (Capital, Pennsylvania, $13.7 million)Hunting Island State Park Project (Coastal Protection, South Carolina, $11.4 million)Tybee Island Shore Protection Project (Coastal Protection, Georgia, $13.8 million)The Charlotte/Sarasota Regional Beach Project involves beach renourishment to restore the critically...

SALT LAKE CITY, Dec. 30, 2019 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Patrick Nelli, Chief Financial Officer, and Adam Brown, Senior Vice President, Investor Relations, will participate in the following upcoming investor conference.J.P. Morgan 38th Annual Healthcare Conference in San Francisco, Monday, January 13 – Wednesday, January 15, 2020, which will include a presentation on Monday, January 13th at 12:00 p.m. PT and a Q&A session at 1:30 p.m. PT. A live audio webcast and replay of this presentation will be available at https://ir.healthcatalyst.com/news-and-events/events-presentations.About Health CatalystHealth Catalyst...

REDWOOD CITY, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.Guardant Health’s management is scheduled to present on Monday, January 13 at 11:30 a.m. Pacific Time.  Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: http://investors.guardanthealth.com.About Guardant HealthGuardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial...

CARLSBAD, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming J.P. Morgan Healthcare conference in San Francisco, California.GenMark’s management is scheduled to present on Wednesday, January 15, 2020 at 2:30pm PT. Interested parties can access a live and archived webcast of the presentation at ir.genmarkdx.com.About GenMark Diagnostics GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s eSensor XT-8® and...

OMAHA, Neb., Dec. 30, 2019 (GLOBE NEWSWIRE) — Werner Enterprises, Inc. (NASDAQ: WERN), one of the nation’s largest transportation and logistics companies, will release its fourth quarter and full year 2019 earnings on Wednesday, February 5, 2020, after the market close. The company will also hold a conference call to discuss the fourth quarter and full year 2019 results and 2020 outlook on the same day, beginning at 4:00 p.m. CT.The news release, live webcast of the earnings conference call, and accompanying slide presentation will be available at www.werner.com in the “Investors” section under “Webcasts & Presentations.” To participate in the conference call, please dial (844) 701-1165 (domestic) or (412) 317-5498 (international). Please mention to the operator that you are dialing in for the Werner...

CARLSBAD, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner® Midline Posterior Fixation System.Mariner Midline is a comprehensive, less invasive posterior fixation system built upon the Mariner platform to simplify the treatment of a wide range of spinal pathologies. Less invasive procedures are typically associated with reduced blood loss, incision size, and hospital stay compared to traditional open procedures.“The full commercial launch of Mariner Midline expands SeaSpine’s procedural solutions to new markets and leverages the Mariner modular technology to facilitate less invasive procedures,” said Dennis Cirino,...

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./TORONTO, Dec. 30, 2019 (GLOBE NEWSWIRE) — Abigail Capital Corporation (TSXV: ACC.P) (“Abigail”) and Climb Credit Inc. (“Climb Credit”) are pleased to announce that they have on December 16, 2019 entered into a non-binding letter of intent (the “LOI”) which outlines the terms and conditions pursuant to which Abigail and Climb Credit have agreed to complete a transaction that will result in a reverse take-over of Abigail by the shareholders of Climb Credit (the “Transaction”). The Transaction, if completed, will constitute Abigail’s “Qualifying Transaction” as such term is defined...

ROUYN-NORANDA, Québec, Dec. 30, 2019 (GLOBE NEWSWIRE) — Pershimex Resources Corporation (TSX-V: PRO) (“Pershimex” or the “Corporation”) is pleased to announce that it has closed a non-brokered private placement of 8,000,000 common shares issued on a flow-through basis, at a price of $0.05 each, for gross proceeds of $400,000 (the “Private Placement”).The Corporation will use the full proceeds of the Private Placement to incur exploration expenditures the Courville property located in the province of Québec.Finder’s fees of $28,000 have been paid to arm-length intermediaries for this Private Placement. The securities issued pursuant to the Private Placement are subject to a hold period of four months and a day ending April 30, 2020.The Private Placement is subject to the final...

ROUYN-NORANDA, Québec, 30 déc. 2019 (GLOBE NEWSWIRE) — Corporation Ressources Pershimex («Pershimex» ou la « Société ») (Bourse de croissance TSX: PRO) annonce qu’elle a complété un placement privé sans l’entremise d’un courtier d’un nombre de 8 000 000 actions ordinaires émises sur une base accréditive, à un prix de 0,05 $ l’action, pour un produit de souscription de 400 000 $ (le « placement privé »).La totalité du produit du placement privé sera engagée en travaux d’exploration sur la propriété minière Courville située dans la province de Québec.Des honoraires d’intermédiation...